Utama › Artritis Psoriatik › California
Kajian klinikal Artritis Psoriatik di California
13 kajian untuk Artritis Psoriatik sedang mencari peserta di lokasi di California.
Bandar di California
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
- Newport Huntington Medical Group, Huntington Beach
- Rheumatology Center of San Diego, San Diego
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07321873Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT03816345A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Up0122 105, Santa Monica
Mengambil pesertaFasa 1
Umur 18 ke atas · Wanita · Dikemas kini 18 Sep 2026 · NCT06888193A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- First OC Dermatology Research Inc., Fountain Valley
- Purushotham & Akther Kotha MD, La Mesa
- Triwest Research Associates LLC, La Mesa
- dan 2 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06671483Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
- Medvin Clinical Research - Riverside ( Site 5115), Riverside
- Cohen Medical Centers ( Site 5111), Thousand Oaks
- Medvin Clinical Research - Tujunga ( Site 5113), Tujunga
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07486960Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, La Jolla
- Clinical Site, Pomona
- Clinical Site, Santa Monica
- dan 2 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- Biovin Enterprises LLC dba Medvin Clinical Research | Covina, CA, Covina
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06671496Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- First OC Dermatology Research Inc., Fountain Valley
- Purushotham & Akther Kotha MD, La Mesa
- Triwest Research Associates LLC, La Mesa
- dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07286058Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Children's Hospital of Los Angeles, Los Angeles
- Mattel Children's Hospital at University of California Los Angeles, Los Angeles
- Stanford University Medical Center, Palo Alto
- dan 2 lagi
Mengambil pesertaKajian pemerhatian
Sehingga umur 21 · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT02418442A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- Pa0019 127, Apple Valley
- Pa0019 111, Covina
- Pa0019 119, Fullerton
- dan 6 lagi
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Jul 2026 · NCT07290036Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
- University of California, San Diego, San Diego
Mengambil peserta
Semua umur · Semua jantina · Dikemas kini 10 Jun 2026 · NCT06586281Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
- Newport Huntington Medical Group /ID# 272764, Huntington Beach
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Dis 2025 · NCT06865105Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
- University of California, San Diego, La Jolla
Mengambil pesertaKajian pemerhatian
Semua umur · Wanita · Dikemas kini 28 Jan 2025 · NCT02103361Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.